Related Experiment Video
Updated: Feb 23, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
The Revised Basel Statements on the Future of Hospital Pharmacy: What Do They Mean for Saudi Arabia?
Hanadi Al Sabban1,2, Ahmed Al-Jedai1,2, Dalia Bajis3
1Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Objectives:
To describe the current hospital pharmacy practice in Saudi Arabia according to the revised Basel statements.
Methods:
A review of the available data based on published literature in the subject area was carried out.
Key Findings:
The original Basel Statements were developed at the 2008 Global Conference on the Future of Hospital Pharmacy in Basel, Switzerland. Representatives from 98 countries, including Saudi Arabia, attended this conference. The revision of the Basel statements simplified and merged many of the original Basel statements. In addition to making the Basel statements more concise, the revision added new statements to reflect global trends and the expanded responsibilities of hospital pharmacists.
Conclusion:
The release of the Basel statements represents an important opportunity to bring Saudi Arabian practices into complete concurrence with international standards and to identify areas that should be prioritized.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Poisoning: Potential Scenarios
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

